About Us » Subgroups

To improve progress towards Global Plan targets and address the challenges in TB drug development, the Working Group on New Drugs is currently focusing on four key areas. Each one of the four Subgroups is composed of expert volunteers committed to addressing key issues that will move the whole field of TB Drug Development forward.

  • Biology/Targets

    Biology/Targets focuses on M. tuberculosis biology, the exchange of information to improve decision making for target selection and treatment strategies, and helps build a global vision for TB drug development.

  • Biology/Targets
    terms of reference

  • Candidates

    Candidates focuses on candidate TB drugs in the global pipeline, and promotes research and collaboration that will result in the creation of affordable, high-quality candidate drugs for the treatment of TB.

  • Candidates
    terms of reference

  • Critical Knowledge and Tools

    Critical Knowledge and tools promotes the understanding and development of tools needed for TB that will support the discovery, testing, or improvement of new TB drugs or treatment strategies that will ultimately be combined into novel TB regimens for clinical trials.

  • Critical Knowledge and Tools
    terms of reference

  • Clinical Trials Capacity

    Clinical Trials Capacity supports successful clinical development with several initiatives, including the building of trials site capacity and identification of regulatory issues and hurdles.

  • Clinical Trials Capacity
    terms of reference